XLONasdaq United States
Market cap
$60.294 M
$9.17 -1.08%
Close of 7 Aug 2026
Revenue
$43.8M
#2787 by revenue
Earnings
-$35.0M
Loss-making
Shares outstanding
5,782,511
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Xilio Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.